J TRANSL INTERN MED 润色咨询

Journal of Translational Internal Medicine

出版年份:暂无数据 年文章数:21 投稿命中率:暂无数据

出版周期:暂无数据 自引率:暂无数据 审稿周期:暂无数据

前往期刊查询

投稿信息

投稿信息
审稿速度
暂无数据 (网友贡献,非官方数据)
投稿命中率
暂无数据
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2022年中国人文章占该期刊总数量60.87%
自引率
暂无数据
年文章数
21
期刊官网
点击查看 (点击次数:496)
点击查看 (点击次数:300次)
作者需知
暂无数据
偏重的研究方向
暂无数据
期刊简介
稿件收录要求

Print ISSN 2450-131X
Online ISSN 2224-4018

Journal of Translational Internal Medicine (JTIM), launched in Dec 2013, is an open access journal publishing articles in all areas of translational internal medicine. The journal focuses on information derived from human disease-related experimentations so as to optimize the communication between basic scientific research and clinical science. It has a cycling nature, namely from basic research to clinical practice and then from clinical practice back to basic research.

Aims and Scope

Journal of Translational Internal Medicine (JTIM) is devoted to promoting science and practice in translational medicine and internal medicine in the world. To this end, JTIM publishes articles from all areas of internal medicine. The journal publishes original articles, rapid communications, editorials, reviews, highlights, perspective and other information closed relevant to translational medicine, internal medicine and related fields. Other types of articles include advanced experience, ideological highlights, and Q&A from scholars and scientists in related fields. JTIM will also launch Special Issues in rapid response to the newest development directions of scientific research fields.

 

JTIM has the ambition to and will become the EXCELLENT international platform for the publication of outstanding studies from all over the world. JTIM is designed to report research progress and the most recent findings in Translational Internal Medicine field, accelerating successful transformation from basic research results to clinically practical theories,diagnosis and treatment techniques, methodologies and drug discovery. With the aims of health care delivery and policy making, JTIM will help to best balance benefits, qualities and costs of medications. At JTIM, we have a challenging mission: to improve the quality of human life and enable people live longer by facilitating disease prevention, treatment and eventually the CURE.

Journal of Translational Internal Medicine is academically supported by:

  • International Society of Translational Sciences,
  • Infectious Diseases Society of China,
  • Chinese Hypertension Committee of Chinese Medical Doctors Association,
  • China Alliance of COPD, China RTI Optimal Treatment Committee,
  • Drug Clinical Assessment Committee of Chinese Pharmaceutical Association.